Astrana Health (ASTH) EPS (Weighted Average and Diluted) (2013 - 2026)

Astrana Health has disclosed EPS (Weighted Average and Diluted) across 14 years of filings, most recently posting $0.29 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at $0.29, up 107.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $0.62 (down 15.07% YoY), and the FY2025 annual result was $0.46, down 48.89% from the prior year.
• EPS (Weighted Average and Diluted) came in at $0.29 for Q1 2026 at Astrana Health, up from $0.13 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.5 in Q3 2022 to a low of -$0.14 in Q4 2024.
• The 5-year median for EPS (Weighted Average and Diluted) is $0.28 (2023), against an average of $0.23.
• Across the five-year window, EPS (Weighted Average and Diluted) surged 425.0% in 2023 and slumped 153.85% in 2024, its largest moves.
• Astrana Health's EPS (Weighted Average and Diluted) stood at -$0.08 in 2022, then soared by 425.0% to $0.26 in 2023, then slumped by 153.85% to -$0.14 in 2024, then surged by 192.86% to $0.13 in 2025, then surged by 123.08% to $0.29 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.29 (Q1 2026), $0.13 (Q4 2025), and $0.01 (Q3 2025), per Business Quant data.